Commentary: Efficacy and safety of intravenous monoclonal antibodies in patients with moderate-to-severe active Graves’ ophthalmopathy: a systematic review and meta-analysis

• Lingxiao Li,
• Jihong Wu

Affiliations

Lingxiao Li

Department of Critical Care Medicine, Wuwei Liangzhou Hospital, Wuwei, Gansu, China

Jihong Wu

Department of Endocrinology, Wuwei Liangzhou Hospital, Wuwei, Gansu, China